1. Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis. (1st April 2017) Authors: El‐Heis, S.; Burke, G.; Gibb, W.; Ardern‐Jones, M. R. Journal: Clinical and experimental dermatology Issue: Volume 42:Number 3(2017) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Myaesthenia gravis exacerbation caused by axillary injection of botulinum toxin A for treatment of hyperhidrosis. (23rd January 2017) Authors: El‐Heis, S.; Burke, G.; Gibb, W.; Ardern‐Jones, M. R. Journal: Clinical and experimental dermatology Issue: Volume 42:Number 3(2017) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Regulation of Multidrug Resistance P‐Glycoprotein in the Developing Blood–Brain Barrier: Interplay between Glucocorticoids and Cytokines. (27th March 2016) Authors: Iqbal, M.; Baello, S.; Javam, M.; Audette, M. C.; Gibb, W.; Matthews, S. G. Journal: Journal of neuroendocrinology Issue: Volume 28:Number 3(2016:Mar.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗